Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Use of clinical characteristics to predict spirometric classification of obstructive lung disease

Steven Pascoe, Wei Wu, Kathryn Collison, Linda Nelsen, Keele Wurst, Laurie Lee
European Respiratory Journal 2016 48: PA4185; DOI: 10.1183/13993003.congress-2016.PA4185
Steven Pascoe
1Respiratory Medicines Development Centre, GSK, Research Triangle Park, NCUnited States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Wu
2Biostatistics, Parexel International, Research Triangle Park, NCUnited States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn Collison
1Respiratory Medicines Development Centre, GSK, Research Triangle Park, NCUnited States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Nelsen
3Value Evidence and Outcomes, GSK, Collegeville, PAUnited States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keele Wurst
4Worldwide Epidemiology, GSK, Collegeville, PAUnited States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurie Lee
5Research and Development, GSK, Stevenage, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 48 no. suppl 60
DOI 
https://doi.org/10.1183/13993003.congress-2016.PA4185

Published By 
European Respiratory Society
Print ISSN 
0903-1936
Online ISSN 
1399-3003
History 
  • Published online November 8, 2016.

Copyright & Usage 
Copyright ©the authors 2016

Author Information

  1. Steven Pascoe1,
  2. Wei Wu2,
  3. Kathryn Collison1,
  4. Linda Nelsen3,
  5. Keele Wurst4 and
  6. Laurie Lee5
  1. 1Respiratory Medicines Development Centre, GSK, Research Triangle Park, NCUnited States
  2. 2Biostatistics, Parexel International, Research Triangle Park, NCUnited States
  3. 3Value Evidence and Outcomes, GSK, Collegeville, PAUnited States
  4. 4Worldwide Epidemiology, GSK, Collegeville, PAUnited States
  5. 5Research and Development, GSK, Stevenage, United Kingdom

Article usage

Article usage: November 2016 to December 2022

AbstractFullPdf
Nov 2016700
Dec 20162100
Jan 20171100
Feb 20171000
Mar 2017900
Apr 20172500
May 20171500
Jun 20171200
Jul 20171400
Aug 20171400
Sep 20171500
Oct 20171000
Nov 2017700
Dec 2017700
Jan 2018400
Feb 2018500
Mar 2018800
Apr 2018900
May 20181500
Jun 2018400
Jul 2018700
Aug 2018400
Sep 2018800
Oct 2018900
Nov 20181300
Dec 2018500
Jan 2019400
Feb 2019300
Mar 2019600
Apr 20191200
May 20191800
Jun 20192000
Jul 20192000
Aug 2019500
Sep 2019400
Oct 2019600
Nov 2019500
Dec 20191100
Jan 2020700
Feb 2020500
Mar 2020700
Apr 20201200
May 2020600
Jun 2020500
Jul 2020900
Aug 20201500
Sep 20201100
Oct 2020500
Nov 20201500
Dec 20201100
Jan 2021100
Feb 2021600
Mar 20211100
Apr 2021800
May 20211500
Jun 2021500
Jul 2021700
Aug 2021600
Sep 20211000
Oct 2021500
Nov 20211600
Dec 20211000
Jan 20222200
Feb 2022400
Mar 2022400
Apr 20221900
May 2022700
Jun 20221000
Jul 2022500
Aug 2022700
Sep 2022700
Oct 2022500
Nov 2022500
Dec 2022200

Altmetrics

Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Use of clinical characteristics to predict spirometric classification of obstructive lung disease
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Use of clinical characteristics to predict spirometric classification of obstructive lung disease
Steven Pascoe, Wei Wu, Kathryn Collison, Linda Nelsen, Keele Wurst, Laurie Lee
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4185; DOI: 10.1183/13993003.congress-2016.PA4185

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Use of clinical characteristics to predict spirometric classification of obstructive lung disease
Steven Pascoe, Wei Wu, Kathryn Collison, Linda Nelsen, Keele Wurst, Laurie Lee
European Respiratory Journal Sep 2016, 48 (suppl 60) PA4185; DOI: 10.1183/13993003.congress-2016.PA4185
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Should pseudomonas aeruginosa be the main target in bronchiectasis?
  • X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients
  • Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD)
Show more 5.2 Monitoring Airway Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society